Health Care
More on Health Care
Washington, D.C. (May 7, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, Rep.
WASHINGTON, DC – Today, Chairs of the House Committees that oversee the Department of Health and Human Services (HHS) voiced their strong opposition to a harmful Trump Administration rule that would roll back Affordable Care Act (ACA) nondiscrimination protections. In a letter, House Ways and Means Committee Chairman Richard E.
House Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ), House Oversight and Reform Chairwoman Carolyn B.
Washington, D.C. (Apr. 2, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Committee Member Rep. Alexandria Ocasio-Cortez issued the following statement after the Food and Drug Administration (FDA) announced it revised its policy of turning away blood donations from gay and bisexual men in light of the long-term impacts of the coronavirus crisis on the nation's blood supply:
On Monday, March 30, 2020, at 11:00 a.m.the Committee will hold a briefingfor Members with Dr. Robert Kadlec, Assistant Secretary for Preparedness and Response at the Department of Health and Human Services (HHS); Brian Shuy, Chief of Staff to Dr.
On Monday, March 30, 2020, at 11:00 a.m.the Committee will hold a briefingfor Members with Dr. Robert Kadlec, Assistant Secretary for Preparedness and Response at the Department of Health and Human Services (HHS); Brian Shuy, Chief of Staff to Dr.
Washington, D.C. (Mar. 3, 2020)—Today, Oversight Committee Chairwoman Carolyn B. Maloney, Economic and Consumer Policy Subcommittee Chairman Raja Krishnamoorthi, National Security Subcommittee Chairman Stephen F. Lynch, and Government Operations Subcommittee Chairman Gerry Connolly sent letters seeking detailed information from the Department of Health and Human Services (HHS) and the Centers for Disease Control Prevention (CDC) regarding the testing, diagnoses, and costs of treating the novel coronavirus (COVID-19).
Washington, D.C. (Feb. 3, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, announced that James Carroll, the Director of the Office of the National Drug Control Policy (ONDCP), has agreed to testify at a hearing on February 27, 2020. The hearing will examine the recently released 2020 National Drug Control Strategy and the Administration's response to the ongoing drug epidemic.
Chairwoman Maloney issued a statement following the release of the 2020 National Drug Control Strategy today:
Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, along with the Chairmen of the Subcommittees on Government Operations, Civil Rights and Civil Liberties, Economic and Consumer Policy, and Environment, announced that four Subcommittees will hold an in-depth, two-day series of hearings to examine the negative effects of regulations proposed by the Trump Administration relating to children's poverty, housing, hunger, and health.